BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33085017)

  • 1. Effect of long-term acid suppression therapy with proton pump inhibitors or H
    Damodharan S; Raj GM; Sakthibalan M; Dakshinamoorthy K; Muraliswaran P
    Ir J Med Sci; 2021 Aug; 190(3):1213-1217. PubMed ID: 33085017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do acid-lowering agents affect vitamin B12 status in older adults?
    Dharmarajan TS; Kanagala MR; Murakonda P; Lebelt AS; Norkus EP
    J Am Med Dir Assoc; 2008 Mar; 9(3):162-7. PubMed ID: 18294598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
    Lam JR; Schneider JL; Zhao W; Corley DA
    JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Induced Vitamin B
    Linder L; Tamboue C; Clements JN
    J Pharm Pract; 2017 Dec; 30(6):639-642. PubMed ID: 27520327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
    Ruscin JM; Page RL; Valuck RJ
    Ann Pharmacother; 2002 May; 36(5):812-6. PubMed ID: 11978157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.
    Termanini B; Gibril F; Sutliff VE; Yu F; Venzon DJ; Jensen RT
    Am J Med; 1998 May; 104(5):422-30. PubMed ID: 9626024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study.
    Damião CP; Rodrigues AO; Pinheiro MF; Cruz RA; Cardoso GP; Taboada GF; Lima GA
    Sao Paulo Med J; 2016; 134(6):473-479. PubMed ID: 28076635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment.
    Sagar M; Janczewska I; Ljungdahl A; Bertilsson L; Seensalu R
    Aliment Pharmacol Ther; 1999 Apr; 13(4):453-8. PubMed ID: 10215728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Vitamin B12 deficiency with long-term PPIs use: A cohort study.
    Mumtaz H; Ghafoor B; Saghir H; Tariq M; Dahar K; Ali SH; Waheed ST; Syed AA
    Ann Med Surg (Lond); 2022 Oct; 82():104762. PubMed ID: 36268318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
    World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
    Qvigstad G; Arnestad JS; Brenna E; Waldum HL
    Scand J Gastroenterol; 1998 Dec; 33(12):1244-8. PubMed ID: 9930386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.